Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
SEC Accession No. 0001193125-23-071344
Filing Date
2023-03-15
Accepted
2023-03-15 16:19:32
Documents
9
Effectiveness Date
2023-03-15

Document Format Files

Seq Description Document Type Size
1 POSASR d457972dposasr.htm POSASR 451426
2 EX-5.1 d457972dex51.htm EX-5.1 27123
3 EX-23.1 d457972dex231.htm EX-23.1 1735
4 EX-FILING FEES d457972dexfilingfees.htm EX-FILING FEES 34140
5 GRAPHIC g457972g01q01.jpg GRAPHIC 255104
6 GRAPHIC g457972g0315091637310.jpg GRAPHIC 2592
7 GRAPHIC g457972g0315091637763.jpg GRAPHIC 1799
8 GRAPHIC g457972g23i89.jpg GRAPHIC 41358
9 GRAPHIC g457972g85h19.jpg GRAPHIC 52674
  Complete submission text file 0001193125-23-071344.txt   996027
Mailing Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POSASR | Act: 33 | File No.: 333-266547 | Film No.: 23735457
SIC: 2836 Biological Products, (No Diagnostic Substances)